BioWorld MedTech

June 13, 2017

Myomo offers robotics industry IPO

Medical robotics company Myomo Inc. goes public with IPO offering of $5 million at $7.50 per share. The Cambridge, Mass., company specializes in mobility devices for the arms and hands. Read More

Patients see sustained metabolic improvement from Endobarrier

Gottlieb says FDA drafting guidance addressing regenerative medicine

Medtronic dives deep with new visual software for a closer view of the brain

Bonesupport goes public, aims to raise $57M

Appointments and advancements

Daily M&A

Other news to note

Product briefs

Regulatory front

BioWorld MedTech's Cardiology Extra

Today's news in brief

BioWorld

BioWorld briefs for May 2, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for May 2, 2025.

CMS vows to put more emphasis on MA plans’ prior authorization

BioWorld MedTech

Physicians aren’t the only ones who see prior authorization (PA) practices as a significant problem, but John Brooks, deputy administrator at CMS, told a med tech...

Filling the NIH funding gap to protect biopharma research

BioWorld

The Trump administration’s broad slash to university research budgets raises pertinent questions over impacts to the biopharma ecosystem, specifically how a...

US flag, stock market chart, White House

100 days of uncertainty

BioWorld

The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...